Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -11.23%808.78M | -3.96%793.14M | 3.00%3.51B | 2.46%1.02B | -2.91%749.34M | 8.65%911.12M | 3.44%825.85M | -1.32%3.4B | -6.25%994.37M | -11.14%771.77M |
| Cost of revenue | -12.97%566.55M | -8.27%565.88M | 1.59%2.61B | 2.14%784.13M | 5.37%560.4M | 4.05%650.98M | -4.56%616.89M | -12.40%2.57B | -20.26%767.73M | -25.18%531.82M |
| Gross profit | -6.88%242.23M | 8.76%227.26M | 7.36%892.78M | 3.57%234.74M | -21.26%188.95M | 22.16%260.13M | 37.46%208.96M | 62.08%831.56M | 131.59%226.64M | 52.14%239.96M |
| Operating expense | -21.62%42.69M | 125.95%51.88M | -27.95%134.12M | -62.94%32.89M | 219.05%155.62M | 52.19%54.47M | -30.10%22.96M | 34.30%186.15M | 109.17%88.75M | 42.09%48.78M |
| Selling and administrative expenses | 5.52%48.73M | 11.63%41.92M | -4.48%187.16M | -12.60%62.85M | -16.93%40.59M | 12.76%46.18M | 9.71%37.55M | 27.88%195.94M | 40.02%71.91M | 37.64%48.86M |
| -Selling and marketing expense | 4.59%22.61M | 3.44%17.49M | 11.78%79.49M | 6.10%22.36M | 8.71%18.6M | 11.08%21.62M | 25.61%16.91M | 17.82%71.11M | 10.94%21.08M | 5.94%17.11M |
| -General and administrative expense | 6.34%26.11M | 18.33%24.43M | -13.75%107.68M | -20.36%40.49M | -30.74%21.99M | 14.29%24.56M | -0.59%20.65M | 34.42%124.84M | 57.09%50.84M | 64.10%31.75M |
| Other operating expenses | -83.78%1.84M | 1,110.90%11.33M | -7.14%2.81M | -66.77%5.83M | 2,128.35%116.5M | 4,840.00%11.36M | 3,127.59%936K | 120.48%3.03M | 3,125.55%17.55M | 1,187.68%5.23M |
| Total other operating income | 156.63%7.88M | -91.15%1.37M | 335.60%55.85M | 4,919.21%35.79M | -72.41%1.46M | -43.06%3.07M | 1,000.50%15.53M | -19.80%12.82M | -92.48%713K | 237.38%5.31M |
| Operating profit | -2.98%199.54M | -5.71%175.38M | 17.55%758.65M | 46.38%201.85M | -82.57%33.33M | 16.09%205.66M | 56.08%186M | 72.36%645.41M | 148.75%137.9M | 54.94%191.18M |
| Net non-operating interest income expense | 26.33%-48.01M | 18.47%-56.12M | 2.97%-263.92M | 0.61%-68.5M | 7.90%-61.43M | 2.70%-65.17M | 0.82%-68.83M | -18.72%-271.99M | -68.45%-68.92M | 4.36%-66.7M |
| Non-operating interest income | 43.74%1.76M | -14.01%1.17M | -11.06%6.01M | 35.93%2.15M | -51.76%1.28M | -8.73%1.22M | 14.62%1.36M | 99.97%6.75M | 51.87%1.58M | 114.15%2.65M |
| Non-operating interest expense | -25.04%49.77M | -18.38%57.29M | -3.16%269.93M | 0.21%70.65M | -9.58%62.71M | -2.82%66.39M | -0.56%70.19M | 19.90%278.74M | 68.04%70.5M | -2.29%69.35M |
| Net investment income | -276.75%-18.91M | 378.90%2.43M | -110.45%-31.35M | -408.32%-41.27M | 218.52%17.25M | 89.05%-5.02M | -107.38%-872K | 79.39%-14.9M | -21.99%13.38M | 111.26%5.42M |
| Gain/Loss on financial instruments designated as cash flow hedges | ||||||||||
| Gain/Loss on derecognition of available-for-sale financial assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -86.99%3.78M | ||
| Income from associates and other participating interests | 8.78%2.01M | -14.20%1.65M | 28.84%6.52M | -90.31%170K | 61.56%2.59M | 78.26%1.85M | 185.59%1.92M | 206.97%5.06M | 1,180.29%1.75M | 10,100.00%1.6M |
| Special income /charges | 0 | 0 | -555.23%-130.29M | -82.60%79K | 8K | -5.11M | 5.11M | -357.21%-19.89M | -93.97%454K | 0 |
| Less:Impairment of capital assets | ---- | ---- | -70.09%633K | ---- | ---- | ---- | ---- | --2.12M | ---- | ---- |
| Less:Other special charges | ---- | ---- | 129.02%1.31M | ---79K | ---8K | ---- | ---- | 108.43%572K | ---- | ---- |
| Less:Write off | --0 | --0 | 646.35%128.35M | ---- | ---- | --5.11M | ---5.11M | 1,915.95%17.2M | ---- | ---- |
| Other non-operating income /expenses | ||||||||||
| Income before tax | 1.83%134.62M | 0.01%123.34M | -1.19%339.62M | 9.18%92.34M | -106.11%-8.26M | 92.28%132.21M | 123.88%123.33M | 47.45%343.7M | 113.81%84.57M | 291.00%135.28M |
| Income tax | 9.89%32.68M | -6.95%26.19M | 26.57%95.2M | 404.23%44.79M | -130.99%-7.48M | 13.01%29.74M | 77.13%28.15M | 62.47%75.22M | -17.27%8.88M | 116.21%24.13M |
| Net income | -0.51%101.94M | 2.06%97.15M | -8.97%244.41M | -37.18%47.55M | -100.71%-785K | 141.44%102.46M | 142.83%95.18M | 43.73%268.48M | 162.65%75.69M | 374.21%111.15M |
| Net income continuous operations | -0.51%101.94M | 2.06%97.15M | -8.97%244.41M | -37.18%47.55M | -100.71%-785K | 141.44%102.46M | 142.83%95.18M | 43.73%268.48M | 162.65%75.69M | 374.21%111.15M |
| Noncontrolling interests | -1.10%36.16M | -36.42%24.92M | 34.80%124.98M | -7.25%28.48M | -21.11%20.75M | 45.29%36.56M | 271.78%39.19M | 93.16%92.71M | 93.45%30.7M | 101.94%26.3M |
| Net income attributable to the company | -0.18%65.78M | 28.99%72.23M | -32.05%119.44M | -57.60%19.07M | -125.38%-21.53M | 281.54%65.9M | 95.40%56M | 26.64%175.77M | 247.48%44.99M | 714.58%84.86M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -0.18%65.78M | 28.99%72.23M | -32.05%119.44M | -57.60%19.07M | -125.38%-21.53M | 281.54%65.9M | 95.40%56M | 26.64%175.77M | 247.48%44.99M | 714.58%84.86M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -0.12%0.0827 | 28.98%0.0908 | -32.05%0.1501 | -57.60%0.024 | -125.42%-0.0271 | 281.57%0.0828 | 95.56%0.0704 | 26.66%0.2209 | 249.38%0.0566 | 713.74%0.1066 |
| Diluted earnings per share | -0.49%0.0814 | 27.21%0.0893 | -32.05%0.1501 | -57.55%0.024 | -125.42%-0.0271 | 276.96%0.0818 | 95.00%0.0702 | 138.55%0.2209 | 249.01%0.0565 | 713.74%0.1066 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0068 | 0 | 0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |